ITCI
Intra-Cellular Therapies Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Market Cap: 6.39 Billion
Primary Exchange: NASDAQ
Website: http://www.intracellulartherapies.com/
Shares Outstanding: 96.8 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.8613700863480315
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1737 trading days
From: 2015-11-27 To: 2022-03-15
Lowest Point:
Intra-Cellular Therapies: Key Catalyst On The Horizon
via: SeekingAlpha at 2019-06-13 07:30:48:000
"Hell is the impossibility of reason." - Oliver Stone Today, we revisit a biopharma name that has an upcoming FDA decision on its main drug candidate due out by the end of September. Company Overview: Intra-Cellular Therapies ( ITCI ) is a New York City based clinical stage biopharma… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|